NCT06710665View on ClinicalTrials.gov

Tumor Regression Grade As Predictor of Adjuvant Therapy

RecruitingOBSERVATIONAL
Enrollment

400

Participants

Timeline

Start Date

October 1, 2024

Primary Completion Date

October 1, 2025

Study Completion Date

October 10, 2025

Conditions
Esophageal Squamous Cell Carcinoma (ESCC)
Interventions
DRUG

Chemotherapy

Chemotherapy

Trial Locations (1)

350001

RECRUITING

Fujian Medical University Union Hospital, Fuzhou

All Listed Sponsors
collaborator

The First Affiliated Hospital of Xiamen University

OTHER

collaborator

Quanzhou First Hospital

OTHER

lead

Fujian Medical University Union Hospital

OTHER